Rachid Benhida

Title: Rachid Benhida: Innovator in Cancer Treatment

Introduction

Rachid Benhida is a prominent inventor based in Nice, France, known for his significant contributions to the field of cancer treatment. With a total of five patents to his name, he has focused on developing innovative compounds that target various types of cancer.

Latest Patents

One of his latest patents is titled "Substituted halo-quinoline derivatives, method of preparation and applications thereof." This invention relates to a compound of general formula (I), where R is OCHCHOCH or OCH, R' is H or OH, and R is Cl, F, Br, or I. The invention also includes pharmaceutically acceptable salts and optical isomers, tautomers, solvates, or isotopic variations of these compounds. These compounds are particularly useful in treating solid tumor cancers, including melanoma, colon, lung, pancreas, kidney, Merkel carcinoma, squamous cell carcinoma, prostate, breast, and bladder cancers. Another notable patent is for "Biguanide derivatives and their rearrangement products for use in the treatment of cancer." This disclosure focuses on biguanide derivatives of formula (I) and their rearrangement products, emphasizing their application in treating melanoma.

Career Highlights

Rachid Benhida has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. His work in these institutions has significantly advanced research in cancer treatment.

Collaborations

Throughout his career, Rachid has collaborated with notable colleagues, including Stephane Rocchi and Robert Ballotti. These partnerships have fostered innovation and contributed to the development of effective cancer therapies.

Conclusion

Rachid Benhida's work exemplifies the impact of innovative research in the medical field, particularly in cancer treatment. His patents and collaborations highlight his commitment to advancing healthcare solutions.